KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Omega Healthcare Investors (OHI) EBITDA Margin (2016 - 2025)

Omega Healthcare Investors' EBITDA Margin history spans 13 years, with the latest figure at 69.87% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 762.0% year-over-year to 69.87%; the TTM value through Dec 2025 reached 70.54%, up 943.0%, while the annual FY2025 figure was 70.54%, 943.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 69.87% at Omega Healthcare Investors, down from 80.06% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 101.44% in Q1 2022 and bottomed at 42.74% in Q1 2023.
  • The 4-year median for EBITDA Margin is 64.62% (2022), against an average of 65.83%.
  • The largest annual shift saw EBITDA Margin crashed -5870bps in 2023 before it surged 1991bps in 2025.
  • A 4-year view of EBITDA Margin shows it stood at 73.51% in 2022, then tumbled by -31bps to 50.67% in 2023, then grew by 23bps to 62.25% in 2024, then grew by 12bps to 69.87% in 2025.
  • Per Business Quant, the three most recent readings for OHI's EBITDA Margin are 69.87% (Q4 2025), 80.06% (Q3 2025), and 70.83% (Q2 2025).